JYHZ2000285 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | License Renew | 2021-01-05 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2022-01-20 | view |
JYHZ2000284 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | License Renew | 2021-01-05 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2022-01-20 | view |
JYHB2100174 | 度他雄胺软胶囊 | dutasteride | Soft capsules | Chemical Drugs | Supplementary Application | 2021-03-04 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-12-14 | view |
JYHZ1900336 | 硫酸阿巴卡韦口服溶液 | abacavir sulfate | Oral solution | Chemical Drugs | License Renew | 2020-01-01 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-11-23 | view |
JXSS2000021 | 美泊利单抗注射液 | mepolizumab | Injection | Biological Products | Import Drug Application | 2020-07-06 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-11-19 | view |
JYHB2000691 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2020-07-06 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-11-12 | view |
JYHZ2100050 | 拉莫三嗪片 | lamotrigine | Tablet | Chemical Drugs | License Renew | 2021-03-11 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-10-19 | view |
JYHZ2100051 | 拉莫三嗪片 | lamotrigine | Tablet | Chemical Drugs | License Renew | 2021-03-11 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-10-19 | view |
JYSZ2100001 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products | License Renew | 2021-01-22 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-08-17 | view |
JYSZ2100002 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products | License Renew | 2021-01-22 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-08-17 | view |
JYSB2000680 | 重组带状疱疹疫苗(CHO细胞) | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2020-12-29 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-08-05 | view |
JYSB2100029 | 重组带状疱疹疫苗(CHO细胞) | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2021-01-20 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-07-13 | view |
JYSB2100028 | 重组带状疱疹疫苗(CHO细胞) | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2021-01-19 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-07-13 | view |
JXSB2100030 | GSK3511294注射液 | depemokimab | Injection | Biological Products(1) | Supplementary Application | 2021-04-02 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-04-02 | view |
JYHB2001889 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2020-09-27 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-03-25 | view |
JXHL2100101 | Linerixibat片 | linerixibat | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-03-24 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-03-23 | view |
JYHB2100202 | 注射用头孢他啶 | ceftazidime | Lyophilized | Chemical Drugs | Supplementary Application | 2021-03-20 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-03-19 | view |
JYSB2000614 | 重组带状疱疹疫苗(CHO细胞) | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2020-12-14 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-03-17 | view |
JYSB2000612 | 重组带状疱疹疫苗(CHO细胞) | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2020-12-14 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-03-17 | view |
JYSB2000617 | 重组带状疱疹疫苗(CHO细胞) | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2020-12-14 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-03-17 | view |